Return On Assets in % of Evoke Pharma Inc from Q2 2014 to Q3 2025

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Evoke Pharma Inc quarterly and annual Return On Assets history and change rate from Q2 2014 to Q3 2025.
  • Evoke Pharma Inc Return On Assets for the quarter ending 30 Sep 2025 was -32%, a 43% increase year-over-year.
  • Evoke Pharma Inc annual Return On Assets for 2024 was -38%, a 59% increase from 2023.
  • Evoke Pharma Inc annual Return On Assets for 2023 was -92%, a 109% decline from 2022.
  • Evoke Pharma Inc annual Return On Assets for 2022 was -44%, a 24% increase from 2021.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Change (%)
Return On Assets, Annual (%)
Return On Assets, YoY Annual Change (%)

Evoke Pharma Inc Quarterly Return On Assets (%)

Period Value YoY Chg Change % Start Date End Date
Q3 2025 -32% +24% +43% 01 Jul 2025 30 Sep 2025
Q2 2025 -34% +35% +51% 01 Apr 2025 30 Jun 2025
Q1 2025 -34% +45% +57% 01 Jan 2025 31 Mar 2025
Q4 2024 -38% +54% +59% 01 Oct 2024 31 Dec 2024
Q3 2024 -56% -10% -22% 01 Jul 2024 30 Sep 2024
Q2 2024 -69% -26% -60% 01 Apr 2024 30 Jun 2024
Q1 2024 -78% -35% -80% 01 Jan 2024 31 Mar 2024
Q4 2023 -92% -48% -109% 01 Oct 2023 31 Dec 2023
Q3 2023 -46% +22% +33% 01 Jul 2023 30 Sep 2023
Q2 2023 -43% +27% +39% 01 Apr 2023 30 Jun 2023
Q1 2023 -44% +23% +34% 01 Jan 2023 31 Mar 2023
Q4 2022 -44% +14% +24% 01 Oct 2022 31 Dec 2022
Q3 2022 -68% -5.2% -8.3% 01 Jul 2022 30 Sep 2022
Q2 2022 -71% -0.43% -0.61% 01 Apr 2022 30 Jun 2022
Q1 2022 -66% +61% +48% 01 Jan 2022 31 Mar 2022
Q4 2021 -58% +123% +68% 01 Oct 2021 31 Dec 2021
Q3 2021 -63% +126% +67% 01 Jul 2021 30 Sep 2021
Q2 2021 -70% +107% +60% 01 Apr 2021 30 Jun 2021
Q1 2021 -128% -21% -19% 01 Jan 2021 31 Mar 2021
Q4 2020 -181% -70% -63% 01 Oct 2020 31 Dec 2020
Q3 2020 -189% -69% -58% 01 Jul 2020 30 Sep 2020
Q2 2020 -177% -58% -49% 01 Apr 2020 30 Jun 2020
Q1 2020 -107% +21% +16% 01 Jan 2020 31 Mar 2020
Q4 2019 -111% +11% +8.8% 01 Oct 2019 31 Dec 2019
Q3 2019 -120% -30% -33% 01 Jul 2019 30 Sep 2019
Q2 2019 -119% +8% +6.3% 01 Apr 2019 30 Jun 2019
Q1 2019 -128% -30% -30% 01 Jan 2019 31 Mar 2019
Q4 2018 -122% -17% -16% 01 Oct 2018 31 Dec 2018
Q3 2018 -90% +22% +20% 01 Jul 2018 30 Sep 2018
Q2 2018 -127% -34% -36% 01 Apr 2018 30 Jun 2018
Q1 2018 -98% +29% +23% 01 Jan 2018 31 Mar 2018
Q4 2017 -105% +31% +23% 01 Oct 2017 31 Dec 2017
Q3 2017 -112% +37% +25% 01 Jul 2017 30 Sep 2017
Q2 2017 -93% +48% +34% 01 Apr 2017 30 Jun 2017
Q1 2017 -127% -4.8% -4% 01 Jan 2017 31 Mar 2017
Q4 2016 -136% -27% -25% 01 Oct 2016 31 Dec 2016
Q3 2016 -149% -50% -50% 01 Jul 2016 30 Sep 2016
Q2 2016 -141% -37% -36% 01 Apr 2016 30 Jun 2016
Q1 2016 -122% -27% -29% 01 Jan 2016 31 Mar 2016
Q4 2015 -109% -31% -40% 01 Oct 2015 31 Dec 2015
Q3 2015 -99% -38% -62% 01 Jul 2015 30 Sep 2015
Q2 2015 -104% -65% -167% 01 Apr 2015 30 Jun 2015
Q1 2015 -95% 01 Jan 2015 31 Mar 2015
Q4 2014 -78% 01 Oct 2014 31 Dec 2014
Q3 2014 -61% 01 Jul 2014 30 Sep 2014
Q2 2014 -39% 01 Apr 2014 30 Jun 2014

Evoke Pharma Inc Annual Return On Assets (%)

Period Value YoY Chg Change % Start Date End Date
2024 -38% +54% +59% 01 Jan 2024 31 Dec 2024
2023 -92% -48% -109% 01 Jan 2023 31 Dec 2023
2022 -44% +14% +24% 01 Jan 2022 31 Dec 2022
2021 -58% +123% +68% 01 Jan 2021 31 Dec 2021
2020 -181% -70% -63% 01 Jan 2020 31 Dec 2020
2019 -111% +11% +8.8% 01 Jan 2019 31 Dec 2019
2018 -122% -17% -16% 01 Jan 2018 31 Dec 2018
2017 -105% +31% +23% 01 Jan 2017 31 Dec 2017
2016 -136% -27% -25% 01 Jan 2016 31 Dec 2016
2015 -109% -31% -40% 01 Jan 2015 31 Dec 2015
2014 -78% 01 Jan 2014 31 Dec 2014
* An asterisk sign (*) next to the value indicates that the value is likely invalid.